Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GI

EndoChoice (GI) Stock Price, News & Analysis

EndoChoice logo

About EndoChoice Stock (NYSE:GI)

Advanced Chart

Key Stats

Today's Range
$8.00
$8.00
50-Day Range
N/A
52-Week Range
$3.64
$9.47
Volume
N/A
Average Volume
131,115 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

EndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.

Receive GI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EndoChoice and its competitors with MarketBeat's FREE daily newsletter.

GI Stock News Headlines

Using Veterans Benefits to Pay for Grad School
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

GI Stock Analysis - Frequently Asked Questions

EndoChoice Holdings Inc (NYSE:GI) announced its earnings results on Wednesday, May, 4th. The medical equipment provider reported ($0.68) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by $0.13. The company's quarterly revenue was up 10.2% on a year-over-year basis.

EndoChoice (GI) raised $101 million in an IPO on Friday, June 5th 2015. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that EndoChoice investors own include Cognyte Software (CGNT), Butterfly Network (BFLY), Coeur Mining (CDE), Denison Mines (DNN), DarioHealth (DRIO), CarParts.com (PRTS) and Air Canada (AC).

Company Calendar

Last Earnings
5/04/2016
Today
5/07/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:GI
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:GI) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners